Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Biochemically Recurrent Prostate Cancer × darolutamide × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Prostate Cancer Non-Metastatic 1 Prostate Cancer Metastatic 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Genital Diseases, Male 1 Biochemically Recurrent Prostate Cancer 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05794906 2026-03-17

ARASTEP

Bayer

Phase 3 Active not recruiting

Biochemically Recurrent Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡